ReviewInternational journal of molecular sciences2019

Heterogeneous Responses to Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors (TKIs) in Patients with Uncommon EGFR Mutations: New Insights and Future Perspectives in this Complex Clinical Scenario.

Alessandro Russo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.